WebApr 5, 2024 · Inhibrx Inc. (NASDAQ: INBX) stock closed at 17.84 per share at the end of the most recent trading day (a -4.95 % change compared to the prior day closing price) with a volume of 374.18K shares and market capitalization of 756.41M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology … WebGet the latest DexCom, Inc. (DXCM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Nutriband enters exclusive manufacturing pact for Diocheck technology
WebAnalyst Sentiment Leaderboard. DIVIDENDS Dividend Calendar Dividends - World WebOct 4, 2024 · October 4, 2024 - 8:00 am. SAN DIEGO, Oct. 4, 2024-- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, announced today that, based on discussions with the U.S. Food and Drug Administration (FDA), there is potential to pursue an … grace bible church newfane
WebApr 12, 2024 · Inhibrx - INBX - Stock Price Today - Zacks Inhibrx (INBX) (Delayed Data from NSDQ) $17.15 USD -0.21 (-1.21%) Updated Apr 6, 2024 04:00 PM ET After-Market: $17.14 -0.01 (-0.06%) 7:58 PM ET Add... WebInhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline … WebThe Inhibrx, Inc. (NASDAQ:INBX) Second-Quarter Results Are Out And Analysts Have Published New Forecasts. Simply Wall St.-6.10%. Aug-09-21 04:38PM: Inhibrx Reports Second Quarter 2024 Financial Results. PR Newswire. Jun-22-21 06:49AM: Inhibrx Launches Mid-Stage Bone Cancer Study With INBRX-109, Amends Loan Agreement With Oxford. grace bible church oakland maine